Berkshire Hathaway (BRK.B) has steadily increased its stakes in Japan’s five trading houses since 2019, with an aggregate investment cost of $13.8 billion by the end of 2024. Yen bond financing has helped limit currency risk and lower borrowing costs, with expectations of $812 million in 2025 dividends against $135 million in interest expenses. Corporate governance reforms and attractive valuations in Japan have made these investments more appealing to foreign investors, enhancing Berkshire’s long-term earnings resilience in an uncertain global landscape.
MetLife and Aflac Incorporated are two other insurers with significant presence and strategic investments in Japan. MetLife’s acquisition of Alico in 2010 positioned it as a leader in Japan’s life insurance sector, while Aflac established Aflac Ventures Japan in 2019 to invest in healthcare and technology startups. Japan remains a key revenue driver for both companies, reflecting their long-term commitment to the market.
Shares of BRK.B have gained 7.9% year to date, outperforming the industry average. However, BRK.B trades at a price-to-book value ratio of 1.57, above the industry average of 1.54, with a Value Score of D. The Zacks Consensus Estimate for BRK.B’s 2025 and 2026 revenues show year-over-year increases, while the EPS estimates remain stable. BRK.B stock currently holds a Zacks Rank #3 (Hold).
Read more at Zacks Investment Research: Why Berkshire Hathaway is Expanding Its Investments in Japan? – August 25, 2025
